Correlation Between Pasithea Therapeutics and Ensysce Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Ensysce Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Ensysce Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Ensysce Biosciences, you can compare the effects of market volatilities on Pasithea Therapeutics and Ensysce Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Ensysce Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Ensysce Biosciences.

Diversification Opportunities for Pasithea Therapeutics and Ensysce Biosciences

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pasithea and Ensysce is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Ensysce Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ensysce Biosciences and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Ensysce Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ensysce Biosciences has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Ensysce Biosciences go up and down completely randomly.

Pair Corralation between Pasithea Therapeutics and Ensysce Biosciences

Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to under-perform the Ensysce Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Pasithea Therapeutics Corp is 2.53 times less risky than Ensysce Biosciences. The stock trades about -0.02 of its potential returns per unit of risk. The Ensysce Biosciences is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  44.00  in Ensysce Biosciences on August 23, 2024 and sell it today you would earn a total of  15.00  from holding Ensysce Biosciences or generate 34.09% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pasithea Therapeutics Corp  vs.  Ensysce Biosciences

 Performance 
       Timeline  
Pasithea Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pasithea Therapeutics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Ensysce Biosciences 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ensysce Biosciences are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Ensysce Biosciences exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pasithea Therapeutics and Ensysce Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pasithea Therapeutics and Ensysce Biosciences

The main advantage of trading using opposite Pasithea Therapeutics and Ensysce Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Ensysce Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ensysce Biosciences will offset losses from the drop in Ensysce Biosciences' long position.
The idea behind Pasithea Therapeutics Corp and Ensysce Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Stocks Directory
Find actively traded stocks across global markets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges